Considerations Regarding Prevention and Treatment of HIV in Adolescents and Young Adults in BC

Presenter:
Tatiana Sotindjo, MD, FRCPC
Adolescent Medicine Specialist Physician
Hudson Scholar in Equity Diversity and Inclusion | 2020-2022
Department of Pediatrics | Division of Adolescent Health and Medicine | Division of Pediatric Infectious Diseases
Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025